ELF Stock Analysis: ELF Beauty | NYSE
Household & Personal Products | NYSE, USA | Market Cap: 5.432m USD | 12M Return: -26.1% | US26856L1035 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 213M
EPS Trend: 3.2%
Qual. Beats: 1
Rev. Trend: 96.8%
Qual. Beats: 3
Warnings
Tailwinds
Seasonality 9.9 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
e.l.f. Beauty, Inc. is a U.S.-based mass-market beauty company that designs, markets, and distributes cosmetics and skin care products globally. Its portfolio spans eye, lip, face, and skin care items sold under the e.l.f. Cosmetics, e.l.f. Skin, Well People, Naturium, and Rhode brands, reaching customers through both national and international retailers and its own e-commerce platforms.
The company was founded in 2004 and is headquartered in Oakland, California, originally operating as J.A. Cosmetics Holdings, Inc. before adopting its current name in April 2016. It trades on the NYSE under the ticker ELF and is classified within the Personal Care Products sub-industry of the broader Consumer Staples sector, reflecting its positioning in everyday, repeat-purchase personal care goods.
Its business model combines a multi-brand portfolio strategy with a hybrid distribution approach, balancing mass-market retail shelf presence with direct-to-consumer digital sales-an approach common among modern personal care companies seeking both scale and consumer data capture.
- Rhode acquisition accelerates premium skincare revenue growth
- China tariff exposure pressures product gross margins
- Affordable pricing captures market share from prestige beauty brands
| Net Income: 59.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 1.12 > 1.0 |
| NWC/Revenue: 29.63% < 20% (prev 31.11%; Δ -1.48% < -1%) |
| CFO/TA 0.12 > 3% & CFO 296.9m > Net Income 59.6m |
| Net Debt (674.7m) to EBITDA (221.9m): 3.04 < 3 |
| Current Ratio: 2.55 > 1.5 & < 3 |
| Outstanding Shares: last quarter (59.7m) vs 12m ago 3.56% < -2% |
| Gross Margin: 74.44% > 18% (prev 70.67%; Δ 3.77% > 0.5%) |
| Asset Turnover: 93.34% > 50% (prev 102.1%; Δ -8.78% > 0%) |
| Interest Coverage Ratio: 2.82 > 6 (EBIT TTM 129.6m / Interest Expense TTM 46.0m) |
| A: 0.21 (Total Current Assets 859.8m - Total Current Liabilities 337.7m) / Total Assets 2.46b |
| B: -0.04 (Retained Earnings -89.3m / Total Assets 2.46b) |
| C: 0.07 (EBIT TTM 129.6m / Avg Total Assets 1.89b) |
| D: 0.90 (Book Value of Equity 1.17b / Total Liabilities 1.29b) |
| Altman-Z'' = 2.69 = A |
| DSRI: 0.77 (Receivables 174.5m/173.4m, Revenue 1.76b/1.34b) |
| GMI: 0.95 (GM 70.67% / 74.44%) |
| AQI: 1.24 (AQ_t 0.63 / AQ_t-1 0.51) |
| SGI: 1.31 (Revenue 1.76b / 1.34b) |
| TATA: -0.10 (NI 59.6m - CFO 296.9m) / TA 2.46b) |
| Beneish M = -2.91 (Cap -4..+1) = A |
As of August 17, 2026, the stock is trading at USD 91.44 with a total of 1,608,389 shares traded. Over the past week, the price has changed by -7.16%, over one month by +22.75%, over three months by +66.68% and over the past year by -26.10%.
Current recommended Stop Loss: 85.70 (which is 6.3% or 1.3 ATR below the current price).
ELF Beauty has received a consensus analysts rating of 4.24. Therefore, it is recommended to buy ELF.
- StrongBuy: 9
- Buy: 3
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 97.3 | 6.4% |
P/E Trailing = 93.9286
P/E Forward = 33.0033
P/S = 20.2399
P/B = 4.8079
P/EG = 1.3707
Revenue TTM = 1.76b USD
EBIT TTM = 129.6m USD
EBITDA TTM = 221.9m USD
Long Term Debt = 802.0m USD (from longTermDebt, last quarter)
Short Term Debt = 30.0m USD (from shortTermDebt, last quarter)
Debt = 1.02b USD (from shortLongTermDebtTotal, last quarter) + Leases 97.3m
Net Debt = 674.7m USD (calculated: Debt 1.02b - CCE 344.2m)
Enterprise Value = 6.11b USD (5.43b + Debt 1.02b - CCE 344.2m)
Interest Coverage Ratio = 2.82 (Ebit TTM 129.6m / Interest Expense TTM 46.0m)
EV/FCF = 21.80x (Enterprise Value 6.11b / FCF TTM 280.2m)
FCF Yield = 4.59% (FCF TTM 280.2m / Enterprise Value 6.11b)
FCF Margin = 15.90% (FCF TTM 280.2m / Revenue TTM 1.76b)
Net Margin = 3.38% (Net Income TTM 59.6m / Revenue TTM 1.76b)
Gross Margin = 74.44% ((Revenue TTM 1.76b - Cost of Revenue TTM 450.5m) / Revenue TTM)
Gross Margin QoQ = 83.20% (prev 72.66%)
Tobins Q-Ratio = 2.48 (Enterprise Value 6.11b / Total Assets 2.46b)
Interest Expense / Debt = 4.51% (Interest Expense 46.0m / Debt 1.02b)
Taxrate = 28.74% (24.0m / 83.6m)
NOPAT = 92.4m (EBIT 129.6m * (1 - 28.74%))
Current Ratio = 2.55 (Total Current Assets 859.8m / Total Current Liabilities 337.7m)
Debt / Equity = 0.87 (Debt 1.02b / totalStockholderEquity, last quarter 1.17b)
Debt / EBITDA = 3.04 (Net Debt 674.7m / EBITDA 221.9m)
Debt / FCF = 2.41 (Net Debt 674.7m / FCF TTM 280.2m)
Total Stockholder Equity = 1.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.16% (Net Income 59.6m / Total Assets 2.46b)
RoE = 5.18% (Net Income TTM 59.6m / Total Stockholder Equity 1.15b)
RoCE = 6.64% (EBIT 129.6m / Capital Employed (Equity 1.15b + L.T.Debt 802.0m))
RoIC = 4.47% (NOPAT 92.4m / Invested Capital 2.06b)
WACC = 10.54% (E(5.43b)/V(6.45b) * Re(11.91%) + D(1.02b)/V(6.45b) * Rd(4.51%) * (1-Tc(0.29)))
Discount Rate = 11.91% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 70.26 | Cagr: 0.94%
[DCF] Terminal Value 71.23% ; FCFF base≈222.1m ; Y1≈254.6m ; Y5≈374.7m
[DCF] Fair Price = 57.46 (EV 4.07b - Net Debt 674.7m = Equity 3.39b / Shares 59.0m; r=10.54% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 3.19 | EPS CAGR: 0.26% | SUE: 4.0 | # QB: 1
Revenue Correlation: 96.84 | Revenue CAGR: 29.94% | SUE: 2.73 | # QB: 3
EPS current Quarter (2026-09-30): EPS=0.58 | Chg30d=-14.53% | Revisions=+12% | Analysts=18
EPS next Quarter (2026-12-31): EPS=0.84 | Chg30d=-28.46% | Revisions=+0% | Analysts=18
EPS current Year (2027-03-31): EPS=3.61 | Chg30d=+9.36% | Revisions=+57% | GrowthEPS=+15.4% | GrowthRev=+20.0%
EPS next Year (2028-03-31): EPS=3.84 | Chg30d=+5.14% | Revisions=+29% | GrowthEPS=+6.4% | GrowthRev=+8.1%
[Analyst] Revisions Ratio: +32% (up=13, down=6)